We are live on ! Find out more
VAM

Visium Asset Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 3.58%
This Fund
S&P 500
This Quarter Est. Return
-5.41%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.88B
AUM Growth
-$780M
Cap. Flow
-$157M
Cap. Flow %
-2.67%
Top 10 Hldgs %
22.93%
Holding
752
New
180
Increased
134
Reduced
143
Closed
277

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$101M
2
CNC icon
Centene
CNC
+$101M
3
ENDP
Endo International plc
ENDP
+$71.2M
4
GILD icon
Gilead Sciences
GILD
+$67.6M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$45.9M

Top Sells

Rank Stock Value
1
PRGO icon
Perrigo
PRGO
+$61.7M
2
BKD icon
Brookdale Senior Living
BKD
+$54.9M
3
LH icon
Labcorp
LH
+$41.3M
4
ZBH icon
Zimmer Biomet
ZBH
+$38.7M
5
PCP
PRECISION CASTPARTS CORP
PCP
+$36.3M

Sector Composition

Rank Sector Weight
1 Healthcare 51.08%
2 Financials 7.25%
3 Energy 5.91%
4 Consumer Discretionary 5.52%
5 Technology 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LH icon
1
Labcorp
LH
$25B
$280M 4.77%
2,786,063
-430,693
-13% -$41.3M
AGN
2
DELISTED
Allergan plc
AGN
$264M 4.49%
984,910
-110,775
-10% -$31.7M
ENDP
3
DELISTED
Endo International plc
ENDP
$188M 3.2%
6,680,749
+1,508,151
+29% +$71.2M
PCRX icon
4
Pacira BioSciences
PCRX
$1.04B
$119M 2.02%
2,239,098
-51,912
-2% -$3.04M
CNC icon
5
Centene
CNC
$30.7B
$104M 1.76%
+3,367,454
New +$101M
BIIB icon
6
Biogen
BIIB
$30B
$99.3M 1.69%
+381,642
New +$101M
ZLTQ
7
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$78M 1.33%
2,871,762
+422,895
+17% +$9.97M
NBIX icon
8
Neurocrine Biosciences
NBIX
$16.8B
$73.7M 1.25%
1,864,222
-337,628
-15% -$13.4M
CI icon
9
Cigna
CI
$73.7B
$71.2M 1.21%
518,635
+271,053
+109% +$37.2M
HR icon
10
Healthcare Realty
HR
$7.28B
$70.1M 1.19%
2,382,215
-695,639
-23% -$19.3M
GILD icon
11
Gilead Sciences
GILD
$162B
$69.1M 1.18%
752,693
+749,179
+21,320% +$67.6M
CNMD icon
12
CONMED
CNMD
$1.39B
$64.5M 1.1%
1,537,247
-269,768
-15% -$10.6M
PFE icon
13
Pfizer
PFE
$143B
$63.6M 1.08%
2,262,318
+513,189
+29% +$14.7M
ALGN icon
14
Align Technology
ALGN
$12.1B
$58.4M 0.99%
803,625
+42,764
+6% +$2.8M
MCK icon
15
McKesson
MCK
$100B
$58.4M 0.99%
371,173
+174,669
+89% +$28.2M
CBPO
16
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$55.5M 0.94%
484,619
+62,016
+15% +$7.28M
HUM icon
17
Humana
HUM
$43.7B
$55.1M 0.94%
301,193
+240,995
+400% +$41.8M
SPNC
18
DELISTED
Spectranetics Corp
SPNC
$52.2M 0.89%
3,592,940
+1,264,967
+54% +$17.5M
ZBH icon
19
Zimmer Biomet
ZBH
$18.2B
$51.9M 0.88%
501,285
-400,035
-44% -$38.7M
KYNB
20
Kyntra Bio
KYNB
$27.2M
$50.3M 0.86%
94,550
+13,273
+16% +$6.61M
SAGE
21
DELISTED
Sage Therapeutics
SAGE
$50M 0.85%
1,559,922
+484,613
+45% +$17.1M
ALNY icon
22
Alnylam Pharmaceuticals
ALNY
$27.5B
$49.7M 0.85%
792,295
+690,948
+682% +$45.9M
SIOX
23
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$48.1M 0.82%
524,096
-110,577
-17% -$11.8M
YHOO
24
DELISTED
Yahoo Inc
YHOO
$48.1M 0.82%
1,305,704
-128,724
-9% -$4.03M
HZNP
25
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$46.5M 0.79%
2,804,261
-156,672
-5% -$2.74M
1
2 3 4 5

Similar funds

FBNAT
FirstMerit Bank N.A. Trustee Akron, Ohio $1.24B AUM 5.12% 1-Year Est. Return
CPS
Counsel Portfolio Services Mississauga, Ontario, Canada $1.01B AUM 2.83% 1-Year Est. Return
LH
Lebenthal Holdings New York $806M AUM 2.13% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
ZA
Zweig Advisers Hartford, Connecticut $586M AUM 1.34% 1-Year Est. Return
FVFIGP
Flagship Ventures Fund IV General Partner Cambridge, Massachusetts $585M AUM
WA
Westport Advisers Westport, Connecticut $542M AUM 2.07% 1-Year Est. Return

Visium Asset Management's Q1 2016 Portfolio in Review

As of Q1 2016, Visium Asset Management held 752 positions worth $5.88B, down 12% from $6.66B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Visium Asset Management's Q1 2016 filing shows 180 new, 134 increased, 143 reduced and 277 closed positions. Its largest new stake was Biogen: 381,642 shares worth $99.3M. The largest sale was Perrigo, an estimated $61.7M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, down from 51% a quarter earlier, followed by Financials and Energy.

  • Visium Asset Management's largest Q1 2016 buy was Biogen: 381,642 shares worth $99.3M.
  • Visium Asset Management added most to Endo International plc in Q1 2016, an estimated $71.2M increase.
  • Visium Asset Management's biggest Q1 2016 reduction was Perrigo, cutting an estimated $61.7M.
  • Visium Asset Management fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $36.3M.
  • Visium Asset Management's ten largest holdings make up 23% of its $5.88B portfolio in Q1 2016.
  • Visium Asset Management opened 180 new positions and closed 277 in Q1 2016.
  • Visium Asset Management's portfolio value fell 12% quarter-over-quarter to $5.88B.

Based on Visium Asset Management's 13F filing for Q1 2016, filed 16 May 2016.